Vasovagal Syncope in the Older Patient

Journal of the American College of Cardiology

Volumn 51, Issue 6, 2008, Pages 599-606

  Tan, Maw Pin ^a   Parry, Steve W ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; ENALAPRIL; ETILEFRINE; FLUDROCORTISONE; METOPROLOL; MIDODRINE; PAROXETINE; PLACEBO; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE;

ABDOMINAL DISCOMFORT; ANGINA PECTORIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIZZINESS; ELECTROCARDIOGRAPHY; HUMAN; HYPERTENSION; INCIDENCE; NAUSEA; PALLOR; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REFLEX; REVIEW; SIDE EFFECT; SWEATING; SYNCOPE; URINARY URGENCY;

AGED; HUMANS; HYPOTENSION; SYNCOPE, VASOVAGAL; TILT-TABLE TEST;

EID: 38849184570     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.11.025     Document Type: Review

References (129)

1. Gowers W.R. Vagal and vaso-vagal attacks. Lancet (1907) 1543-1554
2. Lewis T. Vasovagal syncope and the carotid sinus mechanism. Br Med J (1932) 873-876
3. Nahm F., and Freeman R. Vasovagal syncope: the contributions of Sir William R. Gowers and Sir Thomas Lewis. Arch Neurol 58 (2001) 509-511
4. Brignole M., Menozzi C., Bartoletti A., et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 27 (2006) 76-82
5. Disertori M., Brignole M., Menozzi C., et al. Management of patients with syncope referred urgently to general hospitals. Europace 5 (2003) 283-291
6. Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and prognosis of syncope. N Engl J Med 347 (2002) 878-885
7. Day S.C., Cook E.F., Funkenstein H., and Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 73 (1982) 15-23
8. Kapoor W., Snustad D., Peterson J., Wieland H.S., Cha R., and Karpf M. Syncope in the elderly. Am J Med 80 (1986) 419-428
9. Kenny R.A., Ingram A., Bayliss J., and Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1 (1986) 1352-1355
10. Bloomfield D., Maurer M., and Bigger Jr. J.T. Effects of age on outcome of tilt-table testing. Am J Cardiol 83 (1999) 1055-1058
11. Chen L.Y., Gersh B.J., Hodge D.O., Wieling W., Hammill S.C., and Shen W.K. Prevalence and clinical outcomes of patients with multiple potential causes of syncope. Mayo Clin Proc 78 (2003) 414-420
12. Colman N., Nahm K., Ganzeboom K.S., et al. Epidemiology of reflex syncope. Clin Auton Res 14 Suppl 1 (2004) 9-17
13. Alboni P., Brignole M., and Degli Uberti E.C. Is vasovagal syncope a disease?. Europace 9 (2007) 83-87
14. Ruiz G.A., Peralta A., Gonzalez-Zuelgaray J., and Duce E. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment. Am Heart J 130 (1995) 345-350
15. Benitez del Rosario M.A., and Salinas Martin A. Hydration for control of syncope in palliative care. J Pain Symptom Manage 14 (1997) 5-6
16. Vloka M.E., Tamis J.E., and Steinberg J.S. Neurally mediated syncope in 2 patients with extracardiac disease. Arch Intern Med 159 (1999) 625-627
17. Kala G.K., Lee C., and Coatesworth A.P. Malignant vasovagal syndrome?. Int J Clin Pract 58 (2004) 93-95
18. Venkatraman V., Lee L., and Nagarajan D.V. Lymphoma and malignant vasovagal syndrome. Br J Haematol 130 (2005) 323
19. Abi-Samra F., Maloney J.D., Fouad-Tarazi F.M., and Castle L.W. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. Pacing Clin Electrophysiol 11 (1988) 1202-1214
20. Kaufmann H., and Hainsworth R. Why do we faint?. Muscle Nerve 24 (2001) 981-983
21. Hainsworth R. Syncope: what is the trigger?. Heart 89 (2003) 123-124
22. Ellenbogen K.A., Morillo C.A., Wood M.A., Gilligan D.M., Eckberg D.L., and Smith M.L. Neural monitoring of vasovagal syncope. Pacing Clin Electrophysiol 20 (1997) 788-794
23. Morillo C.A., Eckberg D.L., Ellenbogen K.A., et al. Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation 96 (1997) 2509-2513
24. Mizumaki K., Fujiki A., Tani M., Shimono M., Hayashi H., and Inoue H. Left ventricular dimensions and autonomic balance during head-up tilt differ between patients with isoproterenol-dependent and isoproterenol-independent neurally mediated syncope. J Am Coll Cardiol 26 (1995) 164-173
25. Julu P.O., Cooper V.L., Hansen S., and Hainsworth R. Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans. J Physiol (Lond) 549 (2003) 299-311
26. Theopistou A., Gatzoulis K., Economou E., et al. Biochemical changes involved in the mechanism of vasovagal syncope. Am J Cardiol 88 (2001) 376-381
27. McIntosh S., Da Costa D., and Kenny R.A. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a 'syncope' clinic. Age Ageing 22 (1993) 53-58
28. Alboni P., Brignole M., Menozzi C., et al. Clinical spectrum of neurally mediated reflex syncopes. Europace 6 (2004) 55-62
29. O'Mahony D., and Foote C. Prospective evaluation of unexplained syncope, dizziness, and falls among community-dwelling elderly adults. J Gerontol Series A Biol Sci Med Sci 53 (1998) M435-M440
30. Giese A.E., Li V., McKnite S., et al. Impact of age and blood pressure on the lower arterial pressure limit for maintenance of consciousness during passive upright posture in healthy vasovagal fainters: preliminary observations. Europace 6 (2004) 457-462
31. Kenny R.A., Lyon C.C., Bayliss J., Lightman S.L., and Sutton R. Reduced plasma renin activity in elderly subjects in response to vasovagal hypotension and head-up tilt. Age Ageing 16 (1987) 171-177
32. Ermis C., Samniah N., Sakaguchi S., et al. Comparison of catecholamine response during tilt-table-induced vasovagal syncope in patients <35 to those >65 years of age. Am J Cardiol 93 (2004) 225-227
33. Ruiz G.A., Madoery C., Arnaldo F., Menendez C., and Tentori M.C. Frequency-domain analysis of heart rate variability during positive and negative head-up tilt test: importance of age. Pacing Clin Electrophysiol 23 (2000) 325-332
34. Simpson D.M., and Wicks R. Spectral analysis of heart rate indicates reduced baroreceptor-related heart rate variability in elderly persons. J Gerontol 43 (1988) M21-M24
35. Lipsitz L.A., Mietus J., Moody G.B., and Goldberger A.L. Spectral characteristics of heart rate variability before and during postural tilt. Relations to aging and risk of syncope. Circulation 81 (1990) 1803-1810
36. Brignole M., Menozzi C., Del Rosso A., et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Europace 2 (2000) 66-76
37. Kochiadakis G.E., Papadimitriou E.A., Marketou M.E., Chrysostomakis S.I., Simantirakis E.N., and Vardas P.E. Autonomic nervous system changes in vasovagal syncope: is there any difference between young and older patients?. Pacing Clin Electrophysiol 27 (2004) 1371-1377
38. Kurbaan A.S., Bowker T.J., Wijesekera N., et al. Age and hemodynamic responses to tilt testing in those with syncope of unknown origin. J Am Coll Cardiol 41 (2003) 1004-1007
39. Graham L.A., and Kenny R.A. Clinical characteristics of patients with vasovagal reactions presenting as unexplained syncope. Europace 3 (2001) 141-146
40. Parry S.W., and Kenny R.A. Vasovagal syncope masquerading as unexplained falls in an elderly patient. Can J Cardiol 18 (2002) 757-758
41. McIntosh S.J., Lawson J., and Kenny R.A. Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly. Am J Med 95 (1993) 203-208
42. Gaggioli G., Bottoni N., Mureddu R., et al. Effects of chronic vasodilator therapy to enhance susceptibility to vasovagal syncope during upright tilt testing. Am J Cardiol 80 (1997) 1092-1094
43. Kenny R.A., and Richardson D.A. Carotid sinus syndrome and falls in older adults. Am J Geriatric Cardiol 10 (2001) 97-99
44. Parry S.W., Steen I.N., Baptist M., and Kenny R.A. Amnesia for loss of consciousness in carotid sinus syndrome: implications for presentation with falls. J Am Coll Cardiol 45 (2005) 1840-1843
45. Grubb B.P., Gerard G., Roush K., et al. Differentiation of convulsive syncope and epilepsy with head-up tilt testing. Ann Intern Med 115 (1991) 871-876
46. Zaidi A., Clough P., Cooper P., Scheepers B., and Fitzpatrick A.P. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 36 (2000) 181-184
47. Hyman N.M. Pathology of stroke. In: Evans J.G., Williams T.F., Beattie B.L., Michel J.P., and Wilcock G.K. (Eds). Oxford Textbook of Geriatric Medicine (2000), Oxford University Press, Oxford, England 462-469
48. Coutts S.B., Hu W., and Hill M.D. Syncope and cerebral hypoperfusion. Neurology 60 (2003) 2011
49. Gerstner E., Liberato B., and Wright C.B. Bi-hemispheric anterior cerebral artery with drop attacks and limb shaking TIAs. Neurology 65 (2005) 174
50. Ballard C., Shaw F., McKeith I., and Kenny R. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 51 (1998) 1760-1762
51. Kenny R.A., Shaw F.E., O'Brien J.T., Scheltens P.H., Kalaria R., and Ballard C. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. J Neurol Neurosurg Psychiatry 75 (2004) 966-971
52. Baron-Esquivias G., Gomez S., Aguilera A., et al. Short-term evolution of vasovagal syncope: influence on the quality of life. Int J Cardiol 102 (2005) 315-319
53. Giada F., Silvestri I., Rossillo A., Nicotera P.G., Manzillo G.F., and Raviele A. Psychiatric profile, quality of life and risk of syncopal recurrence in patients with tilt-induced vasovagal syncope. Europace 7 (2005) 465-471
54. Gracie J., Newton J., Norton M., Baker C., and Freeston M. The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope. Europace 8 (2006) 636-643
55. Shaffer C., Jackson L., and Jarecki S. Characteristics, perceived stressors, and coping strategies of patients who experience neurally mediated syncope. Heart Lung 30 (2001) 244-249
56. Tinetti M.E., Mendes de Leon C.F., Doucette J.T., and Baker D.I. Fear of falling and fall-related efficacy in relationship to functioning among community-living elders. J Gerontol 49 (1994) M140-M147
57. Donald I.P., and Bulpitt C.J. The prognosis of falls in elderly people living at home. Age Ageing 28 (1999) 121-125
58. Del Rosso A., Alboni P., Brignole M., Menozzi C., and Raviele A. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol 96 (2005) 1431-1435
59. Alboni P., Brignole M., Menozzi C., et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 37 (2001) 1921-1928
60. Farwell D.J., and Sulke A.N. Does the use of a syncope diagnostic protocol improve the investigation and management of syncope?. Heart 90 (2004) 52-58
61. Brignole M., Alboni P., Benditt D.G., et al. Guidelines on management (diagnosis and treatment) of syncope-update 2004. Europace 6 (2004) 467-537
62. Kenny R.A., O'Shea D., and Parry S.W. The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders. Heart 83 (2000) 564-569
63. Grubb B.P., Wolfe D., Samoil D., et al. Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management. J Am Geriatr Soc 40 (1992) 1123-1128
64. Fitzpatrick A., and Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1 (1989) 658-660
65. Raviele A., Gasparini G., Di Pede F., et al. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J 127 (1994) 103-111
66. Natale A., Sra J., Akhtar M., et al. Use of sublingual nitroglycerin during head-up tilt-table testing in patients >60 years of age. Am J Cardiol 82 (1998) 1210-1213
67. Del Rosso A., Ungar A., Bartoli P., et al. Usefulness and safety of shortened head-up tilt testing potentiated with sublingual glyceryl trinitrate in older patients with recurrent unexplained syncope. J Am Geriatr Soc 50 (2002) 1324-1328
68. Aerts A.J.J., and Dendale P. Diagnostic value of nitrate stimulated tilt testing without preceding passive tilt in patients with suspected vasovagal syncope and a healthy control group. Pacing Clin Electrophysiol 28 (2005) 29-32
69. Parry S.W., Gray J.C., Baptist M., et al. "Front-loaded" glyceryl trinitrate head-up tilt table testing: validation of a rapid first line tilt protocol for the diagnosis of vasovagal syncope. Age Ageing (2008) In press
70. Parry S.W., and Kenny R.A. The role of tilt table testing in neurocardiovascular instability in older adults. Eur Heart J 22 (2001) 370-372
71. Leman R.B., Clarke E., and Gillette P. Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol 22 (1999) 675-677
72. Ammirati F., Colivicchi F., Biffi A., Magris B., Pandozi C., and Santini M. Head-up tilt testing potentiated with low-dose sublingual isosorbide dinitrate: a simplified time-saving approach for the evaluation of unexplained syncope. Am Heart J 135 (1998) 671-676
73. Theodorakis G.N., Livanis E.G., Leftheriotis D., Flevari P., Markianos M., and Kremastinos D.T. Head-up tilt test with clomipramine challenge in vasovagal syndrome-a new tilt testing protocol. Eur Heart J 24 (2003) 658-663
74. Voice R.A., Lurie K.G., Sakaguchi S., Rector T.S., and Benditt D.G. Comparison of tilt angles and provocative agents (edrophonium and isoproterenol) to improve head-upright tilt-table testing. Am J Cardiol 81 (1998) 346-351
75. Fitzpatrick A.P., Lee R.J., Epstein L.M., Lesh M.D., Eisenberg S., and Sheinman M.M. Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation. Heart 76 (1996) 406-411
76. Parry S.W., Nath S., Bourke J.P., Bexton R.S., and Kenny R.A. Adenosine test in the diagnosis of unexplained syncope: marker of conducting tissue disease or neurally mediated syncope?. Eur Heart J 37 (2006) 1396-1400
77. Flammang D., Erickson M., McCarville S., Church T., Hamani D., and Donal E. Contribution of head-up tilt testing and ATP testing in assessing the mechanisms of vasovagal syndrome: preliminary results and potential therapeutic implications. Circulation 99 (1999) 2427-2433
78. Brignole M., Gaggioli G., Menozzi C., et al. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope. Heart 83 (2000) 24-28
79. Flammang D., Antiel M., Church T., et al. Is a pacemaker indicated for vasovagal patients with severe cardioinhibitory reflex as identified by the ATP test?. A preliminary randomized trial. Europace 1 (1999) 140-145
80. Flammang D., Church T., Waynberger M., Chassing A., and Antiel M. Can adenosine 5′-triphosphate be used to select treatment in severe vasovagal syndrome?. Circulation 96 (1997) 1201-1208
81. el-Bedawi K.M., and Hainsworth R. Combined head-up tilt and lower body suction: a test of orthostatic tolerance. Clin Auton Res 4 (1994) 41-47
82. Hainsworth R., and el-Bedawi K.M. Orthostatic tolerance in patients with unexplained syncope. Clin Auton Res 4 (1994) 239-244
83. Kou W.H., Randall D.K., Dorset D.N., and Koch K.S. Immediate reproducibility of tilt-table test results in elderly patients referred for evaluation of syncope or presyncope. Am J Cardiol 80 (1997) 1492-1494
84. Chen X.C., Chen M.Y., Remole S., et al. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 69 (1992) 755-760
85. Foglia-Manzillo G., Giada F., Beretta S., Corrado G., Santarone M., and Raviele A. Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope. Am J Cardiol 84 (1999) 284-288
86. Gieroba Z.J., Newton J.L., Parry S.W., Norton M., Lawson J., and Kenny R.A. Unprovoked and glyceryl trinitrate-provoked head-up tilt table test is safe in older people: a review of 10 years' experience. J Am Geriatr Soc 52 (2004) 1913-1915
87. van Dijk N., Harms M.P., Linzer M., and Wieling W. Treatment of vasovagal syncope: pacemaker or crossing legs?. Clin Auton Res 10 (2000) 347-349
88. Krediet C.T., van Dijk N., Linzer M., van Lieshout J.J., and Wieling W. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106 (2002) 1684-1689
89. Brignole M., Croci F., Menozzi C., et al. Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 40 (2002) 2053-2059
90. Van Dijk J.G., Quartieri F., Blanc J.J., et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope (PC-trial). J Am Coll Cardiol 48 (2006) 1652-1657
91. Brignole M., Menozzi C., Gianfranchi L., Lolli G., Bottoni N., and Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70 (1992) 339-342
92. El-Sayed H., and Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75 (1996) 134-140
93. Alegria J.R., Gersh B.J., Scott C.G., Hodge D.O., Hammill S.C., and Shen W.K. Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 92 (2003) 82-84
94. Madrid A.H., Ortega J., Rebollo J.G., et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 37 (2001) 554-559
95. Sheldon R., Connolly S., Rose S., et al. Prevention Of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113 (2006) 1164-1170
96. Leor J., Rotstein Z., Vered Z., Kaplinsky E., Truman S., and Eldar M. Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope. Am Heart J 127 (1994) 1539-1543
97. Natale A., Newby K.H., Dhala A., Akhtar M., and Sra J. Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects. J Cardiovasc Electrophysiol 7 (1996) 1154-1158
98. Salim M.A., and Di Sessa T.G. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 45 (2005) 484-488
99. Hussain R.M., McIntosh S.J., Lawson J., and Kenny R.A. Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart 76 (1996) 507-509
100. Raj S.R., Rose S., Ritchie D., Sheldon R.S., and Investigators P.I. The Second Prevention of Syncope Trial (POST II)-a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 151 (2006) 1186 e11-7
101. Perez-Lugones A., Schweikert R., Pavia S., et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 12 (2001) 935-938
102. Samniah N., Sakaguchi S., Lurie K.G., Iskos D., and Benditt D.G. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 88 (2001) 80-83
103. Ward C.R., Gray J.C., Gilroy J.J., and Kenny R.A. Midodrine: a role in the management of neurocardiogenic syncope. Heart 79 (1998) 45-49
104. Parry S.W., and Kenny R.A. The management of vasovagal syncope. Q J Med 92 (1999) 697-705
105. Di Girolamo E., Di Iorio C., Sabatini P., Leonzio L., Barbone C., and Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33 (1999) 1227-1230
106. Theodorakis G.N., Leftheriotis D., Livanis E.G., et al. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 8 (2006) 193-198
107. Kelly P.A., Mann D.E., Adler S.W., Fuenzalida C.E., and Reiter M.J. Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing. Pacing Clin Electrophysiol 17 (1994) 573-576
108. Milstein S., Buetikofer J., Dunnigan A., Benditt D.G., Gornick C., and Reyes W.J. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 65 (1990) 1339-1344
109. Raviele A., Brignole M., Sutton R., et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International study. Circulation 99 (1999) 1452-1457
110. Nelson S.D., Stanley M., Love C.J., Coyne K.S., and Schaal S.F. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 151 (1991) 2425-2429
111. Grubb B.P., Temesy-Armos P., Hahn H., and Elliott L. Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med 90 (1991) 6-10
112. Morillo C.A., Leitch J.W., Yee R., and Klein G.J. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22 (1993) 1843-1848
113. Lee T.M., Su S.F., Chen M.F., Liau C.S., and Lee Y.T. Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78 (1996) 480-482
114. Zeng C.Y., Zhu Z., Liu G., et al. Inhibitory effect of enalapril on neurally mediated syncope in elderly patients. J Cardiovasc Pharmacol 31 (1998) 638-642
115. Abe H., Kondo S., Kohshi K., and Nakashima Y. Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. Pacing Clin Electrophysiol 25 (2002) 1454-1458
116. Di Girolamo E., Di Iorio C., Leonzio L., Sabatini P., and Barsotti A. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 100 (1999) 1798-1801
117. Kinay O., Yazici M., Nazli C., et al. Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J 45 (2004) 833-843
118. Lafuente E.A., Martinez L.C., Moguel J.O., et al. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope. Arch Med Res 35 (2004) 416-420
119. Reybrouck T., Heidbuchel H., Van De Werf F., and Ector H. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 25 (2002) 1441-1446
120. Foglia-Manzillo G., Giada F., Gaggioli G., et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 6 (2004) 199-204
121. On Y.K., Park J., Huh J., and Kim J.S. Is home orthostatic self-training effective in preventing neurally mediated syncope?. Pacing Clin Electrophysiol 30 (2007) 638-643
122. Ammirati F., Colivicchi F., and Santini M. Syncope Diagnosis and Treatment Study. I. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104 (2001) 52-57
123. Connolly S.J., Sheldon R., Roberts R.S., and Gent M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33 (1999) 16-20
124. Connolly S.J., Sheldon R., Thorpe K.E., et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289 (2003) 2224-2229
125. Occhetta E., Bortnik M., Audoglio R., Vassanelli C., and INVASY Investigators. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study. Europace 6 (2004) 538-547
126. Raviele A., Giada F., Menozzi C., et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 25 (2004) 1741-1748
127. Brignole M., and Sutton R. Pacing for neurally mediated syncope: is placebo powerless?. Europace 9 (2007) 31-33
128. Sud S., Massel D., Klein G.J., et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med 120 (2007) 54-62
129. Deharo J.C., Brunetto A.B., Bellocci F., et al. DDDR pacing driven by contractility versus DDI pacing in vasovagal syncope: a multicenter, randomized study. Pacing Clin Electrophysiol 26 (2003) 447-450